TABLE 2.

Clinical features of patients infected or colonized with OXA-232 carbapenemase-producing K. pneumoniae isolates

Patient no.	Age	Sex	Underlying condition	Days of hospital stay before infection/total days	Specimen	Invasive procedurea	Prior antibiotic exposure	Antimicrobial therapy	Infection or colonization	Status at hospital discharge
1	4 mo	Male	Neonatal pulmonary hypoplasia, neonatal pneumonia, septicemia	1/180	Sputum	Endotracheal intubation	SAM, MEM, VRO, CRO, IPM	SAM, MEM, FOS, SCF, VRO, CAZ, AMK, CIP	Infection	Died
2	35 d	Male	Congenital laryngeal cartilage dysplasia, malrotation	26/46	Sputum	Endotracheal intubation, PICC	CDZ, CPC, SAM, MEM	FOS, MEM, SCF	Infection	Recovered
3	4 d	Male	Neonatal respiratory distress syndrome, persistent pulmonary hypertension of newborn, congenital heart disease	4/14	Sputum	Endotracheal intubation	SAM, CTX	SAM, MEM	Infection	Recovered
4	16 d	Male	Hyperbilirubinemia, hemolytic disease of newborn	14/23	Urine	None	SAM	SAM	Colonization	Recovered
5	4 mo	Male	Neonatal pulmonary hypoplasia, anemia, neonatal abdominal distension	98/114	Urine	UVC, endotracheal intubation, intestinal surgery	SAM, CPC	MEM, FOS	Infection	Recovered

^aPICC, peripherally inserted central catheter; UVC, umbilical venous catheter; AMK, amikacin; CDZ, cefodizime; CPC, cefepime; CIP, ciprofloxacin; CTX, cefotaxime; CAZ, ceftazidime; SAM, ampicillin-sulbactam; MEM, meropenem; IPM, imipenem; VRO, vancomycin; CRO, ceftriaxone; FOS, fosfomycin; SCF, cefoperazone-sulbactam.